Liver Diseases (2 Vols.) —— Biochemical Mechanisms and New Therapeutic Insights

----- 肝病：生化机制与治疗新见解

ISBN: 9781578083992 出版年：2006 页码：583 CRC Press

VOLUME 1: LIVER DISEASES: PATHWAYS, MEDIATORS AND REGULATION : Section I: Liver Diseases: Mediators and Regulation: Ubiquitin - Proteasome Pathway in the Pathogenesis of Liver Disease Bardag-Gorce Collagen Gene Regulation in the Hepatic Stellate Cell Rippe CYP2F1-Biochemical and Toxicological Aspects and Role in Alcohol-induced Liver Injury Cederbaum Alcohol and Methyl Transfer: Implications for Alcohol-Related Hepatocarcinogenesis Menthionine Adenosyltransferase and S-adenosylmethionine in Liver Health and Disease Acetone Metabolism in the Liver Oxidative Stress and Liver Fibrosis: From Liver Injury to Modulation of Cell Signalling and Response Role of Nitric Oxide in Liver Disorders Renin-Angiotensin System in Liver Fibrosis Section II: Immunological Basis of Liver Injury: Cell and Molecular Mechanisms in the Development of Chronic Liver Inflammation Role of Activated Macrophages in Liver Disease Investigations into Basis for Immune Recognition of Cellular Targets in Primary Biliary Cirrhosis Cross Talk of Hepatocytes and Nonparenchymal Liver Cells in Physiology and Pathology: Monoxides and Eicosanoids Activity of Cytokines in Chronic HCV Infection and Influence of Antiviral Drugs Role of Chemokines in Liver Pathophysiology VOLUME 2: CLINICAL LIVER DISEASES: PATHOPHYSIOLOGY, DIAGNOSTIC AND THERAPEUTIC INSIGHTS: Section III: Clinical Liver Disease Pathophysiology: Nonalcoholic Fatty Liver Diseases: Clinical and Pathophysiological Features Genetic Basis of Hepatocellular Cancer Haemochromatosis: Recent Advances Pathophysiology of Cirrhotic Ascites: Recent Advances Cryptogenic Hepatitis HIV-1 and the Liver Cell Death by Necrosis: Mechanisms and Interception in the Liver Fulminant Hepatic Failure: Etiology, Pathogenesis, and Treatment Section IV: Therapeutic and Diagnostic Insights: Advances in Biology and Therapy of Hepatitis B Virus Infection Hepatitis C Virus: Molecular Virology and Therapeutic Targets Drug Targeting to Hepatic Stellate Cells: A New Strategy to Treat Liver Fibrosis Developing Therapeutic Strategies for Hepatic Fibrosis Liver Disease, Oxidative Stress and Ursodeoxycholic Acid Plasma TGF-b as a Diagnostic and Prognostic Marker Hepatocytes as the Gold Standard for Predicting in-vivo Hepatotoxicity of Xenobiotics Using Accelerated Cytotoxicity Mechanism Screening Techniques